Discovery and validation of acetyl-L-carnitine in serum for diagnosis of major depressive disorder and remission status through metabolomic approach.

Lee, Seungyeon; Mun, Sora; Lee, You-Rim; Choi, Hyebin; Joo, Eun-Jeong; Kang, Hee-Gyoo; Lee, Jiyeong

Lee, Seungyeon; Mun, Sora; Lee, You-Rim; Choi, Hyebin; Joo, Eun-Jeong; Kang, Hee-Gyoo; Lee, Jiyeong.

Afiliación

Lee S; Department of Senior Healthcare, Graduate School, Eulji University, Gyeonggi, South Korea.
Mun S; Department of Biomedical Laboratory Science, College of Health Sciences, Eulji University, Gyeonggi, South Korea.
Lee YR; Department of Senior Healthcare, Graduate School, Eulji University, Gyeonggi, South Korea.
Choi H; Department of Laboratory Medicine, Korea University Anam Hospital, Seoul, South Korea.
Joo EJ; Department of Neuropsychiatry, School of Medicine, Eulji University, Daejeon, South Korea.
Kang HG; Department of Psychiatry, Uijeongbu Eulji Medical Center, Eulji University, Gyeonggi, South Korea.
Lee J; Department of Senior Healthcare, Graduate School, Eulji University, Gyeonggi, South Korea.

Front Psychiatry ; 13: 1002828, 2022.

Article en En | MEDLINE | ID: mdl-36458116

Palabras clave

acetylcarnitine; biomarker; drug treatment; major depressive disorder; metabolite; remission status

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Front Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google